Penpulimab, an anti-PD-1 antibody, for heavily pretreated metastatic nasopharyngeal carcinoma: a single-arm phase II study.
Chen X, Wang W, Zou Q, Zhu X, Lin Q, Jiang Y, Sun Y, Shen L, Wang L, Zou G, Lin X, Lin S, Li M, Wang Y, Xu R, Ao R, Wang R, Lin H, Huang S, Xu T, Li W, Xia M, Xia Y, Wang Z, Li B, Li J, Hu C.
Chen X, et al. Among authors: xu r, xu t.
Signal Transduct Target Ther. 2024 Jun 19;9(1):148. doi: 10.1038/s41392-024-01865-6.
Signal Transduct Target Ther. 2024.
PMID: 38890298
Free PMC article.
Clinical Trial.